Rapid response to treatment with thalidomide in an adolescent with generalized discoid lupus erythematosus. Issue 1 (2nd December 2019)

• Record Type: Journal Article
• Authors: Tran, Benjamin; Yazdani Abyaneh, Mohammad‐Ali; Wu, Julia
• Is Part Of: Pediatric dermatology. Volume 37:Issue 1(2020)
• Page Start: 244
• Page End: 245
• Publication Date: 2019-12-02
• Subjects: alopecia -- connective tissue disease -- systemic therapy -- thalidomide; Pediatric dermatology -- Periodicals; Children -- Diseases -- Periodicals; 618.925
• DOI: 10.1111/pde.14067
• Languages: English
• ISSNs: 0736-8046

Abstract

Abstract: Discoid lupus erythematosus (DLE) is the most common variant of cutaneous chronic lupus erythematosus (CLE). Sun protection, topical corticosteroids, and antimalarials constitute the first‐line options for treatment. In refractory cases, alternative antimalarials, methotrexate, retinoids, and thalidomide have been utilized. We present a case of an adolescent patient with generalized DLE responding rapidly to thalidomide.